HPLC Method for Analysis of Ciraparantag, Arginine on BIST B Column by SIELC Technologies

Ciraparantag, also known as andexanet alfa, is a recombinant modified human factor Xa (FXa) protein with the chemical formula C₂₂H₄₈N₁₂O₂. It is designed to reverse the anticoagulant effects of direct and indirect factor Xa inhibitors, such as rivaroxaban, apixaban, edoxaban, and enoxaparin. Ciraparantag works by binding to the factor Xa inhibitors in the bloodstream, thereby neutralizing their anticoagulant activity. This reversal agent can be particularly useful in emergency situations where rapid reversal of anticoagulation is necessary, such as in cases of severe bleeding or when urgent surgery is required. It has been approved for use in some regions, including the United States, for the treatment of life-threatening or uncontrolled bleeding associated with factor Xa inhibitor therapy. It is typically administered intravenously under the supervision of healthcare professionals.

It’s important to note that ciraparantag is not effective against anticoagulants that do not target factor Xa, such as warfarin. Additionally, like any medication, ciraparantag may have potential side effects, and its use should be carefully monitored by healthcare providers.

Arginine is a semiessential amino acid with the chemical formula (H₂N)(HN)CN(H)(CH₂)₃CH(NH₂)CO₂H. It was originally isolated from yellow lupin seedlings in 1886 by Ernst Schulze and Enst Steiger. Now, commercially, it is obtained through fermentation. Arginine can be typically found in meat, poultry, and fish. You can find detailed UV spectra of Arginine and information about its various lambda maxima by visiting the following link.

Ciraparantag, Arginine can be retained and analyzed on a BIST B column using an analytical method with a simple mobile phase of water, Acetonitrile (MeCN) , and a sulfonic acid as a buffer. This analysis method can be detected using LC MS.

Condition

Description